Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Clinical Chemistry and Laboratory Medicine|October 26, 2012
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcomeLaura Zanotti, Eliana Bignotti, Stefano Calza, et al.
BMC Clinical Pathology|November 16, 2012
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinomaEliana Bignotti, Laura Zanotti, Stefano Calza, et al.
Theranostics|January 18, 2021
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinomaChiara Romani, Elisa Salviato, Alberto Paderno, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 27, 2011
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer managementElisabetta Bandiera, Chiara Romani, Claudia Specchia, et al.
Cancers|November 11, 2022
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial CarcinomaAntonella Ravaggi, Davide Capoferri, Laura Ardighieri, et al.
Scientific Reports|January 31, 2023
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathwaysChiara Romani, Luigi Lorini, Anna Bozzola, et al.
European Journal of Cancer (Oxford, England : 1990)|January 12, 2010
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patientsEliana Bignotti, Paola Todeschini, Stefano Calza, et al.
BMC Cancer|July 29, 2009
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrenceRenata A Tassi, Stefano Calza, Antonella Ravaggi, et al.
Oncotarget|September 30, 2015
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug deliveryChiara Romani, Emiliano Cocco, Eliana Bignotti, et al.
Clinical Chemistry and Laboratory Medicine|September 10, 2013
Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosisElisabetta Bandiera, Laura Zanotti, Aline S C Fabricio, et al.
Pageof 7